-
Clinical Outcome Assessments in the Asia-Pacific Region: Strategy & Implementation
-
How Can Society Sustainably Benefit From Biosimilars? Global Learnings and Policy Recommendations for Australia
-
An Introduction to Network Meta-Analysis
-
Differentiating Between Patient Preferences, Patient Reported Outcomes and Patient Engagement
-
September 7: Budget Impact Analysis I: A 6-Step Approach- Virtual
-
August 31-September 1: Risk-Sharing/Performance-Based Arrangements for Drugs and Other Medical Products- Virtual
-
August 16-17: Model Calibration in R- Virtual
-
Stakeholder Engagement in Value Assessment
-
Data Privacy and Digital Health: The Manufacturers/Payers Perspective
-
July 26-27: Introduction to Modeling Methods - Virtual
-
July 19-20: Multiple Imputation Methods for Addressing Missing Data in Health Economic Evaluation - Virtual
-
July 13-14: Introduction to Use of Electronic Health Record Data for Health Technology Assessment- Virtual
-
June 29-30: Economic Model Review: Quality Control, Strategic Assessment and Reporting Standards- Virtual
-
Distributional Cost-Effectiveness Analysis to Inform Healthcare Decisions
-
June 22-23: Patient Engagement in Medical-Product Research and Development- Virtual
-
Signal - Episode 7
The ISPOR Signal Series welcomes Christopher Lawer, creator of Umio and Health Ecosystem Value Design®, global advisor and educator, and author of Interactional Creation of Health: Experience Ecosystem Ontology, Task and Method.
-
Oncology Endpoints in Reimbursement Decision-Making: Are We Keeping Pace With the Science?
-
Financing Sustainable Healthcare Systems in Latin America
-
June 8-9: Advanced Patient-Reported Outcomes- Virtual
-
Sustainable Access to Biosimilars in the USA and Latin America: Challenges and Potential Solutions